Kathrin Tintelnot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kathrin Tintelnot has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
Michael Seibold
Robert Koch Institute, Division 16: Mycotic and Parasitic Agents and Mycobacteria, Consultant laboratory for Cryptococcosis, Scedosporiosis and Imported Systemic Mycoses, Berlin, Germany
6 shared publicationsAnne Bernhardt
Robert Koch Institute, Division 16: Mycotic and Parasitic Agents and Mycobacteria, Consultant laboratory for Cryptococcosis, Scedosporiosis and Imported Systemic Mycoses, Berlin, Germany
3 shared publications- Carsten Schwarz
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
3 shared publications M. Seibold
Robert Koch Institute, and
3 shared publicationsA. Polak
Aesch, Switzerland
2 shared publicationsDoris Staab
Division of Cystic Fibrosis, Pediatric Pneumology and Immunology, Charité – Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
2 shared publications
Latest Publications
- 28 April 2018
- Published by Springer Nature in International Ophthalmology
- Vol. 39 (6) , 1379-1385
Keratomycosis due to Tintelnotia destructans refractory to common therapy treated successfully with systemic and local terbinafine in combination with polyhexamethylene biguanide
To report on a wearer of rigid gas-permeable contact lenses with a keratomycosis due to Tintelnotia—a new genus of Phaeosphaeriaceae—treated with terbinafine and polyhexamethylene biguanide.
- 28 April 2018
- Published by Springer Nature in International Ophthalmology
- Vol. 39 (6) , 1379-1385
Keratomycosis due to Tintelnotia destructans refractory to common therapy treated successfully with systemic and local terbinafine in combination with polyhexamethylene biguanide
To report on a wearer of rigid gas-permeable contact lenses with a keratomycosis due to Tintelnotia—a new genus of Phaeosphaeriaceae—treated with terbinafine and polyhexamethylene biguanide.
- 1 October 2015
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 305 (7) , 724-728
Cluster analysis of Scedosporium boydii infections in a single hospital
- 1 October 2015
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 305 (7) , 724-728
Cluster analysis of Scedosporium boydii infections in a single hospital
- Open Access
- 2 September 2015
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 53 (8) , 874-879
Pitfalls in Serological Diagnosis ofCryptococcus gattiiInfections
The detection of cryptococcal antigen by latex agglutination tests (LATs), enzyme-linked immunoassays (ELISA), or lateral flow assay (LFA) is an important tool for diagnosis of a Cryptococcus infection. Cerebrospinal fluid and/or serum samples of 10 patients with cryptococcosis due to Cryptococcus gattii or a hybrid of Cryptococcus neoformans and C. gattii were examined by three LATs (the IMMY Latex-Crypto® test, the PastorexTMCrypto Plus, and the Remel Cryptococcus Antigen Test Kit) and the LFA made by Immuno-Mycologics. LATs based on monoclonal antibodies (mAbs) like the PastorexTMCrypto Plus or the Remel Cryptococcus Antigen Test Kit turned out to have an insufficient sensitivity to detect four out of 10 C. gattii infections, including one infection by a hybrid between C. gattii and C. neoformans. Reflecting the ongoing expansion of C. gattii in geographical zones outside of tropical and subtropical areas like Mediterranean countries, Vancouver Island (British Columbia, Canada) and the Pacific Northwest region (USA), these findings are alarming because of the risk of delayed diagnosis of infections caused by C. gattii. Therefore, the preliminary serological screening for cryptococcal antigen in the case of a suspected Cryptococcus infection should be performed by using an assay with a broad range specificity and sensitivity for C. neoformans and C. gattii, including their hybrids.
- 2 September 2015
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 53 (8) , 874-879
Open AccessPitfalls in Serological Diagnosis ofCryptococcus gattiiInfections
The detection of cryptococcal antigen by latex agglutination tests (LATs), enzyme-linked immunoassays (ELISA), or lateral flow assay (LFA) is an important tool for diagnosis of a Cryptococcus infection. Cerebrospinal fluid and/or serum samples of 10 patients with cryptococcosis due to Cryptococcus gattii or a hybrid of Cryptococcus neoformans and C. gattii were examined by three LATs (the IMMY Latex-Crypto® test, the PastorexTMCrypto Plus, and the Remel Cryptococcus Antigen Test Kit) and the LFA made by Immuno-Mycologics. LATs based on monoclonal antibodies (mAbs) like the PastorexTMCrypto Plus or the Remel Cryptococcus Antigen Test Kit turned out to have an insufficient sensitivity to detect four out of 10 C. gattii infections, including one infection by a hybrid between C. gattii and C. neoformans. Reflecting the ongoing expansion of C. gattii in geographical zones outside of tropical and subtropical areas like Mediterranean countries, Vancouver Island (British Columbia, Canada) and the Pacific Northwest region (USA), these findings are alarming because of the risk of delayed diagnosis of infections caused by C. gattii. Therefore, the preliminary serological screening for cryptococcal antigen in the case of a suspected Cryptococcus infection should be performed by using an assay with a broad range specificity and sensitivity for C. neoformans and C. gattii, including their hybrids.
- Open Access
- 1 June 2015
- Published by Microbiology Society in JMM Case Reports
- Vol. 2 (3)
Scedosporium apiospermum: a fungal pathogen causing pneumonia in a patient with cystic fibrosis
Introduction: Scedosporium apiospermum is a slow-growing pathogenic fungus that can cause pneumonia. Diagnosis of this rare filamentous fungus is challenging. To the best of our knowledge, this is the first case describing an acute pulmonary infection caused by this fungal pathogen in a patient with cystic fibrosis (CF). Case presentation: A 35-year-old female with CF, with a 1-month history of irritating cough, increased sputum production and dyspnoea, was admitted to hospital. A chest computed tomography scan revealed new bilateral infiltrations, mediastinal lymphadenopathy and bronchiectasis. Pseudomonas aeruginosa and S. apiospermum were detected in the bronchoalveolar lavage. The patient's clinical status was not improved by standard antibiotic therapy. Antifungal systemic therapy consisting of systemic caspofungin and oral posaconazole against the highly suspected scedosporiosis was initiated, but the clinical outcome was not significantly improved. Antibodies against the S. apiospermum complex were present in the patient's serum. Only after the addition of 50 mg once a day of inhaled liposomal amphotericin B the patient was successfully treated. Conclusion: The patient was cured by a combined therapy of two systemic antimycotic drugs and one local antimycotic drug.
- 1 June 2015
- Published by Microbiology Society in JMM Case Reports
- Vol. 2 (3)
Open AccessScedosporium apiospermum: a fungal pathogen causing pneumonia in a patient with cystic fibrosis
Introduction: Scedosporium apiospermum is a slow-growing pathogenic fungus that can cause pneumonia. Diagnosis of this rare filamentous fungus is challenging. To the best of our knowledge, this is the first case describing an acute pulmonary infection caused by this fungal pathogen in a patient with cystic fibrosis (CF). Case presentation: A 35-year-old female with CF, with a 1-month history of irritating cough, increased sputum production and dyspnoea, was admitted to hospital. A chest computed tomography scan revealed new bilateral infiltrations, mediastinal lymphadenopathy and bronchiectasis. Pseudomonas aeruginosa and S. apiospermum were detected in the bronchoalveolar lavage. The patient's clinical status was not improved by standard antibiotic therapy. Antifungal systemic therapy consisting of systemic caspofungin and oral posaconazole against the highly suspected scedosporiosis was initiated, but the clinical outcome was not significantly improved. Antibodies against the S. apiospermum complex were present in the patient's serum. Only after the addition of 50 mg once a day of inhaled liposomal amphotericin B the patient was successfully treated. Conclusion: The patient was cured by a combined therapy of two systemic antimycotic drugs and one local antimycotic drug.
- 1 April 2015
- Published by Elsevier in The Lancet
- Vol. 385 (9976) , 1476
Arxula adeninivorans causing invasive pulmonary mycosis and fungaemia in cystic fibrosis
- 1 April 2015
- Published by Elsevier in The Lancet
- Vol. 385 (9976) , 1476
Arxula adeninivorans causing invasive pulmonary mycosis and fungaemia in cystic fibrosis
- 1 March 2015
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 14 (2) , 237-241
Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium
- 1 March 2015
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 14 (2) , 237-241
Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium
- 30 December 2014
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 53 (2) , 132-144
Molecular identification of fungal pathogens in nodular skin lesions of cats
In a retrospective study, we investigated 52 formalin-fixed, paraffin-embedded (FFPE) samples from cats with histologically confirmed cutaneous and subcutaneous mycoses to determine if the pathogens could be identified by molecular methods. Aim of the study was to obtain a deep understanding of the spectrum of infectious agents, which, as we hypothesized, was not available by histopathology alone. Detection of feline and fungal DNA was achieved in 92.3% and 94.2% of the samples, respectively. Most of the subcutaneous infections in cats were caused by Alternaria spp. (63.5%), followed by Cryptococcus neoformans (7.7%), Histoplasma capsulatum (5.8%), Sporothrix spp. (3.8%), Aspergillus vitricola, Aureobasidium pullulans, Exophiala attenuata, Fusarium oxysporum, Lecythophora cateniformis, Microsporum canis, and Phialophora sp. (1.9% each). The results from molecular identification indicate that correct identifications of the fungal pathogens by histology alone were rarely possible. The spectrum of fungal pathogens identified after DNA extraction from FFPE samples was much broader than that expected by classical histopathology. This was especially noted in alternariosis in that the micromorphological pattern in tissue was misleading and could be confused with that of cryptococcosis. Due to different susceptibilities to antifungal agents, it is important to arrive at a definitive diagnosis, which might be possible by examination of the fungus recovered in culture and/or molecular methods, in addition to the histopathologic techniques.
- 30 December 2014
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 53 (2) , 132-144
Molecular identification of fungal pathogens in nodular skin lesions of cats
In a retrospective study, we investigated 52 formalin-fixed, paraffin-embedded (FFPE) samples from cats with histologically confirmed cutaneous and subcutaneous mycoses to determine if the pathogens could be identified by molecular methods. Aim of the study was to obtain a deep understanding of the spectrum of infectious agents, which, as we hypothesized, was not available by histopathology alone. Detection of feline and fungal DNA was achieved in 92.3% and 94.2% of the samples, respectively. Most of the subcutaneous infections in cats were caused by Alternaria spp. (63.5%), followed by Cryptococcus neoformans (7.7%), Histoplasma capsulatum (5.8%), Sporothrix spp. (3.8%), Aspergillus vitricola, Aureobasidium pullulans, Exophiala attenuata, Fusarium oxysporum, Lecythophora cateniformis, Microsporum canis, and Phialophora sp. (1.9% each). The results from molecular identification indicate that correct identifications of the fungal pathogens by histology alone were rarely possible. The spectrum of fungal pathogens identified after DNA extraction from FFPE samples was much broader than that expected by classical histopathology. This was especially noted in alternariosis in that the micromorphological pattern in tissue was misleading and could be confused with that of cryptococcosis. Due to different susceptibilities to antifungal agents, it is important to arrive at a definitive diagnosis, which might be possible by examination of the fungus recovered in culture and/or molecular methods, in addition to the histopathologic techniques.
- 24 October 2013
- Published by Springer Nature in Der Pathologe
- Vol. 34 (6) , 534-539
Pilzinfektionen des Zentralnervensystems bei immunkompetentem Wirt
- 24 October 2013
- Published by Springer Nature in Der Pathologe
- Vol. 34 (6) , 534-539
Pilzinfektionen des Zentralnervensystems bei immunkompetentem Wirt
- 24 October 2013
- Published by Springer Nature in Der Pathologe
- Vol. 34 (6) , 503-510
Differenzialdiagnosen beim Nachweis von Hyphen im Gewebe
Usually the detection of hyphae in tissue is unmistakable evidence of a deep mycosis requiring antimycotic treatment. Micromorphology alone rarely allows a specific diagnosis, thus confusion is possible between Candida, Aspergillus, Alternaria and Fusarium species or several other fungal agents. If broad, nearly non-septated hyphae are detected histologically mucormycosis can be suspected. Detection of hyphae in tissue is always a cause for concern because therapeutic consequences must follow. Because therapeutic strategies may differ depending on the specific fungal agent, a suspected diagnosis should be supplemented by other methods, e.g. culture of unfixed specimens, by immunohistology or molecular biological methods.
- 24 October 2013
- Published by Springer Nature in Der Pathologe
- Vol. 34 (6) , 503-510
Differenzialdiagnosen beim Nachweis von Hyphen im Gewebe
Usually the detection of hyphae in tissue is unmistakable evidence of a deep mycosis requiring antimycotic treatment. Micromorphology alone rarely allows a specific diagnosis, thus confusion is possible between Candida, Aspergillus, Alternaria and Fusarium species or several other fungal agents. If broad, nearly non-septated hyphae are detected histologically mucormycosis can be suspected. Detection of hyphae in tissue is always a cause for concern because therapeutic consequences must follow. Because therapeutic strategies may differ depending on the specific fungal agent, a suspected diagnosis should be supplemented by other methods, e.g. culture of unfixed specimens, by immunohistology or molecular biological methods.